HYL Hyloris Pharmaceuticals SA

4.562USD4.150 EUR · EBR-3.49%Mkt Cap: 127.73M USDP/E: —

Hyloris Pharmaceuticals SA operates as a specialty pharmaceutical company in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific. The company offers Maxigesic IV for the treatment of post-operat…